• Molecular NameGrepafloxacin
  • SynonymNA
  • Weight359.401
  • Drugbank_IDDB00365
  • ACS_NO119914-60-2
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)0.13
  • pkaN/A
  • LogD (pH=7, predicted)-2.18
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.86
  • LogSw (predicted, AB/LogsW2.0)0.06
  • Sw (mg/ml) (predicted, ACD/Labs)0.44
  • No.of HBond Donors2
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds3
  • TPSA72.88
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn oral broad-spectrum quinoline antibacterial agent used to treat bacterial infections.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability70.0
  • Protein binding50.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A